Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment

Biliary tract cancers are rare cancers with poor prognosis due to a lack of therapeutic options, especially after the failure of first-line systemic treatment. Targeted treatments for this clinical situation are promising and have entered clinical practice. We aimed to describe the overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Doleschal, Bernhard, Taghizadeh, Hossein, Webersinke, Gerald, Piringer, Gudrun, Schreil, Georg, Decker, Jörn, Aichberger, Karl J., Kirchweger, Patrick, Thaler, Josef, Petzer, Andreas, Schmitt, Clemens A., Prager, Gerald W., Rumpold, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507096/
https://www.ncbi.nlm.nih.gov/pubmed/37723192
http://dx.doi.org/10.1038/s41598-023-42083-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507096/
https://www.ncbi.nlm.nih.gov/pubmed/37723192
http://dx.doi.org/10.1038/s41598-023-42083-4

Ejemplares similares